P
PMV Pharmaceuticals
A Doylestown, Penn-based developer of p53-targeted small molecule drugs for the treatment of cancer
About PMV Pharmaceuticals
PMV Pharmaceuticals, Inc. is a pioneering biotechnology company focused on developing innovative treatments for cancer. The company specializes in creating first-in-class p53 regulators, targeting the most commonly mutated protein in human cancers. By harnessing over three decades of p53 biology, PMV Pharma combines a unique biological understanding with a strong focus on pharmaceutical development.
Read full description
PMV Pharma operates in the biotechnology and pharmaceutical market, primarily serving patients suffering from various forms of cancer. The company's business model revolves around the research, development, and commercialization of novel cancer therapies. Revenue is generated through the successful development and eventual sale or licensing of their proprietary treatments.
The company is led by a team of industry and academic thought leaders who are dedicated to discovering new treatments for human diseases. This leadership team brings together extensive experience in both scientific research and pharmaceutical development, ensuring a robust approach to tackling cancer.
PMV Pharma's core mission is to harness the power of p53 to treat cancer, offering hope and potential cures to millions of patients worldwide. The company is headquartered in Cranbury, NJ, and continues to make significant strides in the field of oncology.
At a glance
- Founded
- 2013
- Headquarters
- Cranbury Township, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning PMV Pharmaceuticals.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
OrbiMed
InterWest Partners
Osage University Partners
Series B and later8 investors entered at this stage
Nextech Invest
Viking Global Investors- ECEuclidean Capital
Boxer Capital
RA Capital Management
Avoro Capital Advisors
Wellington Management- DADenali Advisors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
20 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about PMV Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PMV Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.